Nodal metabolic tumour volume on baseline 18 F-FDG PET/CT and overall survival in stage II and III NSCLC patients undergoing curative-intent chemoradiotherapy/radiotherapy.
Ramin AlipourNick BucknellMathias BresselSarah EverittMichael MacManusShankar SivaMichael S HofmanTim AkhurstRodney J HicksAmir IravaniPublished in: Journal of medical imaging and radiation oncology (2021)
In node-positive stage II and III NSCLC patients who underwent 18 F-FDG PET/CT-guided target delineation curative-intent concurrent CRT/RT, metabolic parameters did not appear to provide independent prognostication.
Keyphrases
- locally advanced
- rectal cancer
- small cell lung cancer
- prognostic factors
- patients undergoing
- end stage renal disease
- lymph node
- ejection fraction
- neoadjuvant chemotherapy
- newly diagnosed
- chronic kidney disease
- radiation therapy
- squamous cell carcinoma
- peritoneal dialysis
- heart failure
- epidermal growth factor receptor
- atrial fibrillation